From: The expression and survival significance of sodium glucose transporters in pancreatic cancer
Variables | Univariable | Multivariable | ||
---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age (years) | Â | 0.176 | Â | 0.103 |
 < 64 | Ref |  | Ref |  |
 ≥ 64 | 1.578 (0.815–3.058) |  | – |  |
Sex | Â | 0.993 | Â | 0.269 |
 Female | Ref |  | Ref |  |
 Male | 0.997 (0.493–2.015) |  | – |  |
TNM stage | Â | 0.074 | Â | 0.062 |
 I | Ref |  | Ref |  |
 II | 2.591 (0.830–8.087) | 0.101 | 3.111 (0.979–9.886) | 0.054 |
 III | 3.080 (1.172–8.089) | 0.022* | 3.145 (1.198–8.260) | 0.020* |
Grade | Â | 0.053 | Â | 0.034* |
 I | Ref |  | Ref |  |
 II | 1.843 (0.883–3.874) | 0.104 | 2.257 (1.044–4.882) | 0.039* |
 III | 2.091 (0.909–4.811) | 0.083 | 2.881 (1.190–6.977) | 0.019* |
SMV/SMA invasion | Â | 0.385 | Â | 0.747 |
 No | Ref |  | Ref |  |
 Yes | 1.331 (0.699–2.536) |  | – |  |
History of diabetes | Â | 0.637 | Â | 0.550 |
 No | Ref |  | Ref |  |
 Yes | 1.209 (0.549–2.666) |  | – |  |
SGLT-1 | Â | 0.051 | Â | 0.015* |
 Low | Ref |  | Ref |  |
 High | 0.508 (0.257–1.004) |  | 0.419 (0.207–0.846) |  |